Outpatient High-Dose Urokinase Lock: A Quick Answer to Blocked Tunneled Cuffed Catheters
ABSTRACT Introduction: Tunneled Cuffed Catheters (TCC) in haemodialysis are often lost to thrombotic complications. Thrombolytic agents like urokinase are used for thrombolysis of blocked catheters. Inpatient administration of such thrombolytic agents is problematic and expensive for patients and i...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
JCDR Research and Publications Private Limited
2020-06-01
|
| Series: | Journal of Clinical and Diagnostic Research |
| Subjects: | |
| Online Access: | https://jcdr.net/articles/PDF/13756/44595_CE[Ra1]_F(SHU)_PF1(AG_KM)_PFA(KM)_PB(AG_KM)_PN(SL).pdf |
| _version_ | 1818147630206681088 |
|---|---|
| author | Subho Banerjee Himanshu V Patel Nilavav M Shah Rutul M Dave Keshab Sil Divyesh P Engineer Vivek B Kute |
| author_facet | Subho Banerjee Himanshu V Patel Nilavav M Shah Rutul M Dave Keshab Sil Divyesh P Engineer Vivek B Kute |
| author_sort | Subho Banerjee |
| collection | DOAJ |
| description | ABSTRACT
Introduction: Tunneled Cuffed Catheters (TCC) in haemodialysis are often lost to thrombotic complications. Thrombolytic agents like urokinase are used for thrombolysis of blocked catheters. Inpatient administration of such thrombolytic agents is problematic and expensive for patients and increases burden on hospitals.
Aim: To evaluate the efficay and safety of high-dose urokinase lock used for thrombolysis of TCCs on outpatient basis and whether thromolysed catheters achieve adequete survival.
Materials and Methods: Catheters inserted over a 12-month period, starting September 2017 were followed prospectively (n=183 TCCs). Catheter dysfunction was defined as inability to aspirate blood from any one port or blood-flow of <250 mL/min or high arterial/venous pressures. Non-mechanical or non-positional flow-dysfunction was treated with urokinase lock (50,000 units/port) with 5000 U/mL of heparin, total lock volume equal to the catheter dead volume. The solution was kept for 24 hours. Patency rates, need for repeat locks and overall survival was evaluated. Kaplan-meier survival analysis and binary logistic regression was done to evaluate survival and factors associated with need for urokinase rescue.
Results: There were 57 episodes of flow-dysfunction during the 16-month follow-up period (n=159 TCCs, as rest were lost to follow-up). Flow improved in 48 (84.2%) and was completely restored in 41 (71.9%) cases. Seventeen (29.8%) cases needed repeat locks. Twenty-two catheters were lost to flow-related dysfunction. Overall survival of catheters needing urokinase rescue was non-inferior to catheters not needing such intervention (p=0.78). No prelock coagulopathy or postlock bleeding episodes were seen.
Conclusion: Urokinase lock protocol has high efficacy and safety. It allows acceptable survival of TCCs developing thrombotic dysfunction. |
| first_indexed | 2024-12-11T12:38:18Z |
| format | Article |
| id | doaj.art-780607b2e0a84e26b98e72808b4c35ba |
| institution | Directory Open Access Journal |
| issn | 2249-782X 0973-709X |
| language | English |
| last_indexed | 2024-12-11T12:38:18Z |
| publishDate | 2020-06-01 |
| publisher | JCDR Research and Publications Private Limited |
| record_format | Article |
| series | Journal of Clinical and Diagnostic Research |
| spelling | doaj.art-780607b2e0a84e26b98e72808b4c35ba2022-12-22T01:07:04ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2020-06-01146OC09OC1210.7860/JCDR/2020/44595.13756Outpatient High-Dose Urokinase Lock: A Quick Answer to Blocked Tunneled Cuffed CathetersSubho Banerjee0Himanshu V Patel1Nilavav M Shah2Rutul M Dave3Keshab Sil4Divyesh P Engineer5Vivek B Kute6Assistant Professor, Department of Nephrology, Institute of Kidney Diseases and Research Center and Institute of Transplant Sciences, Ahmedabad, Gujarat, India.Professor, Department of Nephrology, Institute of Kidney Diseases and Research Center and Institute of Transplant Sciences, Ahmedabad, Gujarat, India.Senior Resident, Department of Nephrology, Institute of Kidney Diseases and Research Center and Institute of Transplant Sciences, Ahmedabad, Gujarat, India.Senior Resident, Department of Nephrology, Institute of Kidney Diseases and Research Center and Institute of Transplant Sciences, Ahmedabad, Gujarat, India.Senior Resident, Department of Nephrology, Institute of Kidney Diseases and Research Center and Institute of Transplant Sciences, Ahmedabad, Gujarat, India.Associate Professor, Department of Nephrology, Institute of Kidney Diseases and Research Center and Institute of Transplant Sciences, Ahmedabad, Gujarat, India.Professor, Department of Nephrology, Institute of Kidney Diseases and Research Center and Institute of Transplant Sciences, Ahmedabad, Gujarat, India.ABSTRACT Introduction: Tunneled Cuffed Catheters (TCC) in haemodialysis are often lost to thrombotic complications. Thrombolytic agents like urokinase are used for thrombolysis of blocked catheters. Inpatient administration of such thrombolytic agents is problematic and expensive for patients and increases burden on hospitals. Aim: To evaluate the efficay and safety of high-dose urokinase lock used for thrombolysis of TCCs on outpatient basis and whether thromolysed catheters achieve adequete survival. Materials and Methods: Catheters inserted over a 12-month period, starting September 2017 were followed prospectively (n=183 TCCs). Catheter dysfunction was defined as inability to aspirate blood from any one port or blood-flow of <250 mL/min or high arterial/venous pressures. Non-mechanical or non-positional flow-dysfunction was treated with urokinase lock (50,000 units/port) with 5000 U/mL of heparin, total lock volume equal to the catheter dead volume. The solution was kept for 24 hours. Patency rates, need for repeat locks and overall survival was evaluated. Kaplan-meier survival analysis and binary logistic regression was done to evaluate survival and factors associated with need for urokinase rescue. Results: There were 57 episodes of flow-dysfunction during the 16-month follow-up period (n=159 TCCs, as rest were lost to follow-up). Flow improved in 48 (84.2%) and was completely restored in 41 (71.9%) cases. Seventeen (29.8%) cases needed repeat locks. Twenty-two catheters were lost to flow-related dysfunction. Overall survival of catheters needing urokinase rescue was non-inferior to catheters not needing such intervention (p=0.78). No prelock coagulopathy or postlock bleeding episodes were seen. Conclusion: Urokinase lock protocol has high efficacy and safety. It allows acceptable survival of TCCs developing thrombotic dysfunction.https://jcdr.net/articles/PDF/13756/44595_CE[Ra1]_F(SHU)_PF1(AG_KM)_PFA(KM)_PB(AG_KM)_PN(SL).pdfcatheter lockcatheter thrombosisfibrinolytic agentshaemodialysisvascular access |
| spellingShingle | Subho Banerjee Himanshu V Patel Nilavav M Shah Rutul M Dave Keshab Sil Divyesh P Engineer Vivek B Kute Outpatient High-Dose Urokinase Lock: A Quick Answer to Blocked Tunneled Cuffed Catheters Journal of Clinical and Diagnostic Research catheter lock catheter thrombosis fibrinolytic agents haemodialysis vascular access |
| title | Outpatient High-Dose Urokinase Lock: A Quick Answer to Blocked Tunneled Cuffed Catheters |
| title_full | Outpatient High-Dose Urokinase Lock: A Quick Answer to Blocked Tunneled Cuffed Catheters |
| title_fullStr | Outpatient High-Dose Urokinase Lock: A Quick Answer to Blocked Tunneled Cuffed Catheters |
| title_full_unstemmed | Outpatient High-Dose Urokinase Lock: A Quick Answer to Blocked Tunneled Cuffed Catheters |
| title_short | Outpatient High-Dose Urokinase Lock: A Quick Answer to Blocked Tunneled Cuffed Catheters |
| title_sort | outpatient high dose urokinase lock a quick answer to blocked tunneled cuffed catheters |
| topic | catheter lock catheter thrombosis fibrinolytic agents haemodialysis vascular access |
| url | https://jcdr.net/articles/PDF/13756/44595_CE[Ra1]_F(SHU)_PF1(AG_KM)_PFA(KM)_PB(AG_KM)_PN(SL).pdf |
| work_keys_str_mv | AT subhobanerjee outpatienthighdoseurokinaselockaquickanswertoblockedtunneledcuffedcatheters AT himanshuvpatel outpatienthighdoseurokinaselockaquickanswertoblockedtunneledcuffedcatheters AT nilavavmshah outpatienthighdoseurokinaselockaquickanswertoblockedtunneledcuffedcatheters AT rutulmdave outpatienthighdoseurokinaselockaquickanswertoblockedtunneledcuffedcatheters AT keshabsil outpatienthighdoseurokinaselockaquickanswertoblockedtunneledcuffedcatheters AT divyeshpengineer outpatienthighdoseurokinaselockaquickanswertoblockedtunneledcuffedcatheters AT vivekbkute outpatienthighdoseurokinaselockaquickanswertoblockedtunneledcuffedcatheters |